Shree Ganesh Remedies (BOM:540737) 3-Year EBITDA Growth Rate : 20.30% (As of Dec. 2023)

View and export this data going back to 2017. Start your Free Trial

What is Shree Ganesh Remedies 3-Year EBITDA Growth Rate?

Shree Ganesh Remedies's EBITDA per Share for the three months ended in Dec. 2023 was ₹7.45.

During the past 12 months, Shree Ganesh Remedies's average EBITDA Per Share Growth Rate was 50.50% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was 20.30% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 26.60% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was 27.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 11 years, the highest 3-Year average EBITDA Per Share Growth Rate of Shree Ganesh Remedies was 63.90% per year. The lowest was -9.00% per year. And the median was 30.25% per year.

Competitive Comparison of Shree Ganesh Remedies's 3-Year EBITDA Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Shree Ganesh Remedies's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Shree Ganesh Remedies's 3-Year EBITDA Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Shree Ganesh Remedies's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Shree Ganesh Remedies's 3-Year EBITDA Growth Rate falls into.

Shree Ganesh Remedies 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Shree Ganesh Remedies (BOM:540737) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Shree Ganesh Remedies 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Shree Ganesh Remedies's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Shree Ganesh Remedies (BOM:540737) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shree Ganesh Remedies Ltd (BOM:540737) » Definitions » 3-Year EBITDA Growth Rate

Traded in Other Exchanges

890181:India

Address

Plot No. 6011-12, GIDC Industrial Estate, Ankleshwar, GJ, IND, 393002

Website

https://www.ganeshremedies.com

Shree Ganesh Remedies Ltd manufactures drug intermediates, chemicals and specialty fine chemicals for the pharmaceutical industry. It offers pharmaceutical and specialty chemical products. Some of the products offered by the company includes Trityl chloride, Furoyl chloride, and Dinitolmide, among others. The business of the company comes under the primary segment of Bulk Drug Intermediaries.

Shree Ganesh Remedies (BOM:540737) Headlines

No Headlines